Phase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and NeckJennifer L. Leddon, Trisha M. Wise‐Draper, Sarah Palackdharry et al.|Clinical Cancer Research|2022Cited by 26
Adjuvant nivolumab following salvage resection in head and neck squamous cell carcinoma patients previously treated with definitive therapy: A single-arm phase II multi-institutional study.Jennifer L. Leddon, Trisha M. Wise‐Draper, Sulsal Haque et al.|Journal of Clinical Oncology|2021Cited by 5